Top Story

Repeat testing necessary to detect HIV among infants receiving ART via breast-feeding

February 27, 2015

SEATTLE — WHO recommendations for HIV testing 6 weeks after breast-feeding cessation may need to be re-evaluated, as study findings presented at CROI 2015 suggest testing at that interval failed to identify HIV infection among infants exposed to ART via breast-feeding.

“In settings with limited resources and an unsafe water supply, the WHO guidelines recommend that HIV-infected mothers breast-feed uninfected infants for at least 1 year while taking antiretroviral drugs,” study researcher Caroline C. King, PhD, of the CDC, said during a press conference. “These antiretroviral drugs limit HIV transmission while reducing the high risk for infant disease and death associated with formula feeding that relies on an unsafe water supply.

Meeting News Coverage

Delayed HCV therapy may increase liver-related deaths

February 27, 2015
SEATTLE — Deferring treatment for hepatitis C virus infection 1 year or more after diagnosis or until evidence of advanced liver disease may increase liver-related…
Severe fibrosis, cirrhosis prevalent in birth cohort of HCV patients Meeting News Coverage

Severe fibrosis, cirrhosis prevalent in birth cohort of HCV patients

February 27, 2015
SEATTLE — Many adults with hepatitis C virus born between 1945 and 1965 had severe fibrosis or cirrhosis, according to data presented at CROI 2015.“Our…

ACIP confirms recommendation for annual influenza vaccination

February 27, 2015
In a unanimous decision, the CDC’s Advisory Committee on Immunization Practices supported the recommendation that all people aged 6 months and older be vaccinated…
thumbnail for video 4083320513001 Meeting News CoverageVideo

Video: Highlights in cancer and HIV treatments at CROI 2015

February 27, 2015
Infectious Disease News Editorial Board member Paul Volberding, MD, reviews HIV and cancer treatment data presented here at CROI 2015. Highlights include cervical…
More News Headlines »
CME CNE CPE Video
Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes

This activity is supported by an educational grant from Bristol-Myers Squibb.

Protease inhibitors (PIs) have played an instrumental role in decreasing mortality andmorbidity among HIV-infected…
More »
Meeting News Coverage Video
thumbnail for video 4083036415001

Video: PrEP promising, but requires more exploration

February 26, 2015
SEATTLE — Raphael J. Landovitz, MD, of the
More »
CME
HCV Consults: Volume 1, Number 3

HCV Consults: Volume 1, Number 3

This activity is supported by educational grants from AbbVie and Genentech, Inc.

More »
morganatic-roan